Generation Bio Co (GBIO)

$1.39

+0.26

(+23.01%)▲

Market is closed - opens 8 PM, 04 Dec 2023

Performance

  • $1.16
    $1.55
    $1.39
    downward going graph

    16.55%

    Downside

    Day's Volatility :25.13%

    Upside

    10.29%

    downward going graph
  • $0.86
    $7.35
    $1.39
    downward going graph

    38.13%

    Downside

    52 Weeks Volatility :88.3%

    Upside

    81.09%

    downward going graph

Returns

PeriodGeneration Bio Co
3 Months
-71.46%
6 Months
-64.63%
1 Year
-76.79%
3 Years
-97.31%

Highlights

Market Capitalization
77.0M
Book Value
$3.52
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.97
Wall Street Target Price
9.25
Profit Margin
0.0%
Operating Margin TTM
-1461.18%
Return On Assets TTM
-20.68%
Return On Equity TTM
-45.81%
Revenue TTM
3.0M
Revenue Per Share TTM
0.05
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-124.4M
Diluted Eps TTM
-1.97
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.93
EPS Estimate Next Year
-1.97
EPS Estimate Current Quarter
-0.5
EPS Estimate Next Quarter
-0.42

Analyst Recommendation

Buy
    64%Buy
    35%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Generation Bio Co(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
11
11
Hold
5
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 565.47%

Current $1.39
Target $9.25

Technicals Summary

Sell

Neutral

Buy

Generation Bio Co is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Generation Bio Co
Generation Bio Co
39.0%
-64.63%
-76.79%
-97.31%
-94.37%
Moderna, Inc.
Moderna, Inc.
12.07%
-38.83%
-56.22%
-44.17%
329.19%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.48%
10.12%
6.32%
61.32%
112.97%
Novo Nordisk A/s
Novo Nordisk A/s
-0.53%
27.78%
58.23%
194.69%
336.14%
Seagen, Inc.
Seagen, Inc.
-0.96%
8.88%
73.78%
20.15%
232.63%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-6.74%
5.21%
9.27%
54.9%
90.18%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Generation Bio Co
Generation Bio Co
NA
NA
NA
-1.93
-0.46
-0.21
0.0
3.52
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-11.52
-0.22
-0.07
0.0
35.32
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
22.78
22.78
9.01
42.5
0.17
0.09
0.01
234.47
Novo Nordisk A/s
Novo Nordisk A/s
43.04
43.04
2.03
2.62
0.89
0.22
0.01
20.77
Seagen, Inc.
Seagen, Inc.
NA
NA
18.53
-4.16
-0.28
-0.13
0.03
13.52
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
26.52
26.52
0.41
15.04
0.23
0.14
0.02
64.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Generation Bio Co
Generation Bio Co
Buy
$77.0M
-94.37%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$29.6B
329.19%
24.73
-38.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$87.0B
112.97%
22.78
30.47%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$470.4B
336.14%
43.04
35.11%
Seagen, Inc.
Seagen, Inc.
Hold
$40.0B
232.63%
NA
-32.61%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$91.0B
90.18%
26.52
35.94%

Institutional Holdings

  • FMR Inc

    12.79%

  • T. Rowe Price Associates, Inc.

    11.31%

  • Bellevue Group AG

    5.49%

  • T. Rowe Price Investment Management,Inc.

    5.33%

  • BlackRock Inc

    5.09%

  • Artal Group S A

    4.27%

Corporate Announcements

  • Generation Bio Co Earnings

    Generation Bio Co’s price-to-earnings ratio stands at None

    Read More

Company Information

generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. we are a community of creative problem-solvers and independent thinkers. we are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. to learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our twitter feed, @lifetimegenetx.

Organization
Generation Bio Co
Employees
150
CEO
Dr. Cameron Geoffrey McDonough M.D.
Industry
Health Technology

Discover More

FAQs